Summary:
A Clinical study to investigate how safe a new SARS-COV-2 and influenze vaccine (mRNA-1083) is amnd wjether it helps the immune system fight viruses in healthy adult participants more than or equal to >50 years of age.
Qualified Participants Must:
• Must be 50 years or older
•
Must be a healthy adult
Qualified Participants May Receive:
Qualified participants will recieve a total compensation of $1,040